However, these effects were almost completely eliminated by SPINK1-specific shRNAs (Supplementary Fig. 4a), which retained normal proliferative potential of stromal cells but resulted in essentially reversed phenotypes of recipient cancer cells (Supplementary Fig. 4b–d). Here, SPINK1 is linked to cancer.